← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$19K

Shares

523

Price

$37

Filed

Mar 13

Insider

Name

Vivaldi Coelho Rogerio

Title

CIK

0001610381

Roles

Director

Transaction Details

Transaction Date

2026-03-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,300

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $36.08 per share. The range of sales prices on the transaction date was $35.65 to $36.53 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $36.77 per share. The range of sales prices on the transaction date was $36.69 to $36.89 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.

Filing Info

Accession No.

0001628280-26-017797

Form Type

4

Issuer CIK

0001658247

Vivaldi Coelho Rogerio's History

Date Ticker Type Value
2026-03-12 CRNX $162K
2026-03-12 CRNX $19K
2026-03-06 VTRS M $0
2026-03-06 VTRS M $0
2026-03-06 VTRS M $0
2026-03-06 VTRS M $0
2026-03-06 VTRS A $0
2025-06-11 CRNX A $0
2025-06-11 CRNX A $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Vivaldi Coelho Rogerio $162K 2026-03-12
Schilke Tobin
Chief Financial Officer
$266K 2026-03-03
Okey Stephanie $119K 2026-03-03
Struthers Richard Scott
President & CEO
$822K 2026-03-16
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08
Knight Jeff E.
Chief Operating Officer
$370K 2026-03-16
Betz Stephen F.
Chief Scientific Officer
$397K 2026-03-16
Kalofonos Isabel
Chief Commercial Officer
2026-02-23